A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

NCT01042652 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV
HIV Infections

Interventions

DRUG: Raltegravir

Sponsor

Centers for Disease Control and Prevention, China

Collaborators

[object Object]